March 1972

Disseminated Intravascular Coagulation

Author Affiliations

From the Department of Surgery, Harvard Medical School; Surgical Service, Beth Israel Hospital, Boston. Dr. Damus is an academic surgical trainee from the University of California Medical School, Los Angeles, under the sponsorship of an Academic Surgical Training Grant from the National Institute of General Medical Sciences, National Institutes of Health.

Arch Surg. 1972;104(3):262-265. doi:10.1001/archsurg.1972.04180030010005

In the past decade the phenomenon of disseminated intravascular coagulation has gained increasing prominence in the discussion of disease states familiar to the surgeon. This review was prompted by the emergence of new tests to diagnose the condition, by a growing controversy over the significance of certain laboratory abnormalities suggesting its presence, and by an even more difficult dilemma concerning therapy. Since several recent comprehensive reviews of the subject are available,1-6 only those aspects of particular interest to the surgeon will be considered here. Following a brief treatment of the pathophysiology of intravascular coagulation, we deal with the more clinical aspects of the condition.

Normal Events in Coagulation: Definition of Disseminated Coagulation  Gelation of fibrinogen, the visible manifestation of clotting blood, is the end result of a complex series of enzymatic events. The penultimate step is the formation of the potent proteolytic enzyme, thrombin, which cleaves the fibrinogen molecule.

First Page Preview View Large
First page PDF preview
First page PDF preview